NO971687D0 - Diazepinoindoler som forsfodiesterase IV-inhibitorer - Google Patents

Diazepinoindoler som forsfodiesterase IV-inhibitorer

Info

Publication number
NO971687D0
NO971687D0 NO971687A NO971687A NO971687D0 NO 971687 D0 NO971687 D0 NO 971687D0 NO 971687 A NO971687 A NO 971687A NO 971687 A NO971687 A NO 971687A NO 971687 D0 NO971687 D0 NO 971687D0
Authority
NO
Norway
Prior art keywords
hydrogen
racemic forms
diazepinoindoles
indolyl
haloalkyl
Prior art date
Application number
NO971687A
Other languages
English (en)
Other versions
NO971687L (no
Inventor
Yves Pascal
Indres Moodley
Alain Pierre Calvet
Jean Louis Junien
Original Assignee
Jouveinal Inst Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Inst Rech filed Critical Jouveinal Inst Rech
Publication of NO971687D0 publication Critical patent/NO971687D0/no
Publication of NO971687L publication Critical patent/NO971687L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO971687A 1994-10-14 1997-04-11 Diazepinoindoler som forsfodiesterase IV-inhibitorer NO971687L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9412282A FR2725719B1 (fr) 1994-10-14 1994-10-14 Diazepino-indoles inhibiteurs de phosphodiesterases iv
PCT/FR1995/001354 WO1996011690A1 (fr) 1994-10-14 1995-10-13 Diazepino-indoles inhibiteurs de phosphodiesterases iv

Publications (2)

Publication Number Publication Date
NO971687D0 true NO971687D0 (no) 1997-04-11
NO971687L NO971687L (no) 1997-06-13

Family

ID=9467863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971687A NO971687L (no) 1994-10-14 1997-04-11 Diazepinoindoler som forsfodiesterase IV-inhibitorer

Country Status (24)

Country Link
US (1) US5852190A (no)
EP (1) EP0785789B1 (no)
JP (1) JPH10507447A (no)
KR (1) KR970706826A (no)
CN (1) CN1097459C (no)
AT (1) ATE223720T1 (no)
AU (1) AU703773B2 (no)
BR (1) BR9509353A (no)
CA (1) CA2200628A1 (no)
CZ (1) CZ111497A3 (no)
DE (1) DE69528189T2 (no)
DK (1) DK0785789T3 (no)
ES (1) ES2181793T3 (no)
FR (1) FR2725719B1 (no)
HU (1) HUT77411A (no)
NO (1) NO971687L (no)
NZ (1) NZ294642A (no)
PL (1) PL319659A1 (no)
PT (1) PT785789E (no)
RU (1) RU2174517C2 (no)
SK (1) SK282766B6 (no)
UA (1) UA42793C2 (no)
WO (1) WO1996011690A1 (no)
ZA (1) ZA958669B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) * 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv
FR2776660B1 (fr) * 1998-03-27 2000-05-12 Parke Davis Diazepino-indoles de phosphodiesterases iv
MXPA02001830A (es) 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
KR100641802B1 (ko) 1999-12-28 2006-11-02 에자이 가부시키가이샤 술폰아미드 함유 복소환 화합물
WO2001064669A1 (en) * 2000-03-03 2001-09-07 Pfizer Products Inc. Pyrazole ether derivatives as anti-inflammatory/analgesic agents
EP1161949A1 (en) 2000-06-09 2001-12-12 Warner-Lambert Company Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
DE10148290A1 (de) * 2001-09-29 2003-04-17 Bayer Cropscience Gmbh Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840947A (en) * 1986-10-14 1989-06-20 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic piperidin-4-yl-tetracyclic benzodiazepines and use thereas
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them
US5248679A (en) * 1988-09-09 1993-09-28 Fujisawa Pharmaceutical Co., Ltd. Tricyclic compounds
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.

Also Published As

Publication number Publication date
AU703773B2 (en) 1999-04-01
EP0785789B1 (fr) 2002-09-11
BR9509353A (pt) 1997-12-30
EP0785789A1 (fr) 1997-07-30
JPH10507447A (ja) 1998-07-21
FR2725719A1 (fr) 1996-04-19
CA2200628A1 (fr) 1996-04-25
CZ111497A3 (cs) 1998-01-14
CN1160352A (zh) 1997-09-24
US5852190A (en) 1998-12-22
RU2174517C2 (ru) 2001-10-10
MX9702637A (es) 1997-07-31
SK44897A3 (en) 1998-12-02
PL319659A1 (en) 1997-08-18
WO1996011690A1 (fr) 1996-04-25
FR2725719B1 (fr) 1996-12-06
DE69528189T2 (de) 2003-01-09
KR970706826A (ko) 1997-12-01
DK0785789T3 (da) 2003-01-20
PT785789E (pt) 2002-12-31
ES2181793T3 (es) 2003-03-01
HUT77411A (hu) 1998-04-28
UA42793C2 (uk) 2001-11-15
NZ294642A (en) 2001-06-29
SK282766B6 (sk) 2002-12-03
ZA958669B (en) 1997-04-14
ATE223720T1 (de) 2002-09-15
DE69528189D1 (de) 2002-10-17
CN1097459C (zh) 2003-01-01
AU3749495A (en) 1996-05-06
NO971687L (no) 1997-06-13

Similar Documents

Publication Publication Date Title
NO971687D0 (no) Diazepinoindoler som forsfodiesterase IV-inhibitorer
RU2203274C2 (ru) Спироциклические ингибиторы металлопротеаз
NO20065012L (no) Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
TW200745034A (en) New compounds
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MY143245A (en) 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
DE60324685D1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin-wiederaufnahme-inhibitoren
RS49684B (sr) Upotreba derivata 7-(2-oksa-5,8- diazabiciklo[4.3.0]non-8-il)-hinolon- karbonske kiseline i nafthiridonkarbonske kiseline za pripremanje leka za terapiju helikobakter-pilori infekcija i sa time povezanim gastroduodenalnim oboljenjima
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
NO20010487L (no) Disubstituert maleimidforbindelse og farmasøytisk anvendelse herav
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
MY146599A (en) New azetidine compounds
NO20045351L (no) 1-[(indol-3-yl)karbonyl] piperazin-derivater
HUP9903893A2 (hu) Eljárás szívelégtelenségnek ciklopentánnal kondenzált heterogyűrűs endotelin-antagonistákkal történő kezelésére
MY133207A (en) Substituted benzolactam compaunds
PT1140925E (pt) 3,4-di-hidro-2h-benzo¬1,4|oxazinil-metil-¬3-(1h-indol-3il)-alquil|-aminas
HUP0002826A2 (hu) 6-Azauracil-származékok, eljárás előállításukra, alkalmazásuk gyulladások elleni gyógyszer előállítására és az ilyen kompozíciók
FI955933A0 (fi) Abeo-ergoliinijohdannaiset 5HT1A-ligandeina
TW200510300A (en) Amino alcohol compounds
NO934881L (no) Benzotiazolderivater, fremgangsmåte for deres fremstilling og farmasöytisk preparat derav
SE0301744D0 (sv) New compounds
GB0427491D0 (en) Process and compounds
TW200612968A (en) Oligosaccharide derivatives containing with heterocycle

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application